glp-1 fitness news medications are reshaping the future of weight management, and the industry has a pivotal role to play. At the #HFAEuropeanCongress, we're bringing together leading experts to discuss how training and Why exercise is essential for
Description
Ford TC, Downey LA, Simpson T, McPhee G, Oliver C, Stough C

Our Scientific Affairs team made the trip to New Orleans for the #ADASciSessions, where we presented new real-world GLP-1 research, including: Better Sleep, More Energy, and Less Daytime Sleepiness on Ro: evaluating sleep apnea outcomes among patients treated with tirzepatide on Ro

The study demonstrates that quantitative target engagement of dual agonists can be assessed by PET.

Novo Nordisk the manufacturer of several GLP-1 receptor agonists such as liraglutide and semaglutide has said that it envisages intermittent supply shortages over the next 18 months.

These GLP-1 drugs are ubiquitous in life - helping people manage diabetes and, hopefully, reducing their risk

Wegovy (semaglutide) is conditionally approved in the U.S
